Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Hormone therapy in transgender people requires careful monitoring due to potential health risks and lack of standardized test values.

Methods accurately measure tamsulosin hydrochloride and finasteride in combined dosages.

The conclusion is that hair supplement ingredients may be unsafe and should be disclosed and proven safe before use.

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

The new method improves finasteride's effectiveness for hair loss treatment.

Human liver enzyme DHEA ST helps process minoxidil.

Disease-specific tools better assess alopecia areata's impact on quality of life.

A new drug strategy improves hair loss treatment with better results and safety.

The compound 4c effectively inhibits the enzyme linked to hair loss.

The objective approach for creating search strategies is as effective as the traditional method and might be better and more efficient.

The FDA did not approve a testosterone drug because of safety concerns.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

PRP treatments for hair loss need standard protocols to be reliable.

Bicalutamide is more effective and safer than spironolactone for treating female hair loss.

A new accurate method was developed to measure Minoxidil and Aminexil in solutions.

Cochrane systematic reviews have better methodological quality than non-Cochrane ones, and improvements are needed for the latter.

Cell-based screening methods are useful and cost-effective for drug discovery but have pros and cons.

Reconstructed skin models are useful for studying how skin processes certain chemicals.

Ethosomes improve drug delivery through the skin but face stability challenges.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

The comprehensive treatment with biomimetic peptide lotion was effective for hair loss.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

A method was created in 2005 to identify minoxidil, a hair growth ingredient, in products using two types of capillary zone electrophoresis, and it found that most products had about 2% minoxidil.

Injectable biomimetic gels can help heal tissues and deliver drugs but need improvements in strength and delivery.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

New, simple, and cost-effective methods can accurately measure Minoxidil in medicines.